tbuckley/cabot-search huggingface dataset:
Multiple Discipline Research Forum
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Molecular epidemiology of LQTS in a Cohort of 267 probands Carlo Napolitano, Elena Ronchetti, Mirella Memmi, Janni Nastoli, Giovanna Faggiano, Donata Cappelletti, Peter J. Schwartz, Silvia G. Priori. Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy, Dept. of Cardiology, University of Pavia, IRCCS Policlinico S Matteo, Pavia, Italy
Journal: Journal of the American College of Cardiology (2001)
An inhibitory spinal cord neuron
Authors: E. A. Neale
Journal: JAMA (1980)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
INTERCELLULAR STRUGGLES AND ANTICELLULAR SERUMS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Physicians' attitudes toward using deception
Authors: R. Baker
Journal: JAMA (1989)

<h3>In Reply.—</h3> We appreciate the interest shown by those who wrote concerning our work and we hereby reply. Dr Emanuel undercuts his protest that we did not employ his schema for evaluating risk: no needle-stick data support the suggestion that any physician anywhere is likely to stick oneself 5 to 10 times per year. This is not only an unverifiable assumption in the literature, it is a priori preposterous. Such a physician belongs in a different, safer profession, where the practitioners use their feet, not their hands. Dr Sarewitz takes issue with the "equal weight" of a procedure for a sick patient and a dead patient. We will not repeat our arguments about the physician-patient relationship and the low risk of contagion (which is not the same as favorable outcome of illness), but the reader is referred to them. Intuitively, we agree that an obligation that is life-saving or life-preserving
Emerging Functions of IL-33 in Homeostasis and Immunity
Authors: Gaelen K. Dwyer, Louise M. D'Cruz, Hēth R. Turnquist
Journal: Annual Review of Immunology (2022)

Our understanding of the functions of the IL-1 superfamily cytokine and damage-associated molecular pattern IL-33 continues to evolve with our understanding of homeostasis and immunity. The early findings that IL-33 is a potent driver of type 2 immune responses promoting parasite expulsion, but also inflammatory diseases like allergy and asthma, have been further supported. Yet, as the importance of a type 2 response in tissue repair and homeostasis has emerged, so has the fundamental importance of IL-33 to these processes. In this review, we outline an evolving understanding of IL-33 immunobiology, paying particular attention to how IL-33 directs a network of ST2 + regulatory T cells, reparative and regulatory macrophages, and type 2 innate lymphoid cells that are fundamental to tissue development, homeostasis, and repair.
Current Comment
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Journal of Oral Surgery, Chicago
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
Authors: Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy
Journal: Journal of the American College of Cardiology (2009)
Summary of the national Halothane Study. Possible association between halothane anesthesia and postoperative hepatic necrosis
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
DISCUSSION ON GASTRIC DISEASES.
Journal: JAMA (1898)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CHEMICAL CHANGES IN THE BLOOD OF THE DOG IN EXPERIMENTAL BILE PERITONITIS
Authors: Allen M. Ziegler, Thomas G. Orr
Journal: The Journal of Experimental Medicine (1931)

1. Changes in the chemistry of the blood of dogs with experimental bile peritonitis are here reported. 2. In all animals that died, a bile ascites was found. 3. Dogs dying of bile peritonitis showed a constant increase in the blood non-protein and urea nitrogen, and a fall in the chlorides.
Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancer
Authors: Bo Cheng, Kaikai Ding, Pengxiang Chen, Jianxiong Ji, Tao Luo, Xiaofan Guo, Wei Qiu, Chunhong Ma, Xue Meng, Jian Wang, Jinming Yu, Yuan Liu
Journal: Cancer Communications (2022)

Second-generation programmed cell death-protein 1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors, such as bintrafusp alfa (M7824), SHR-1701, and YM101, have been developed to simultaneously block PD-1/PD-L1 and transforming growth factor-beta/transforming growth factor-beta receptor (TGF-β/TGF-βR). Consequently, it is necessary to identify predictive factors of lung cancer patients who are not only resistant to PD-1/PD-L1 inhibitors but also sensitive to bifunctional drugs. The purpose of this study was to search for such predictors.Multivariable Cox regression was used to study the association between the clinical outcome of treatment with PD-1/PD-L1 inhibitors and lymphocyte recovery after lymphopenia in lung cancer patients. Murine CMT167 lung cancer cells were engineered to express the firefly luciferase gene and implanted orthotopically in the lung of syngeneic mice. Bioluminescence imaging, flow cytometry, and immunohistochemistry were employed to determine response to immunotherapy and function of tumor-infiltrating immune cells.For lung cancer patients treated with anti-PD-1/PD-L1 antibodies, poor lymphocyte recovery was associated with a shorter progression-free survival (PFS; P < 0.001), an accumulation of regulatory T cells (Tregs), and an elimination of CD8+ T cells in the peripheral blood. Levels of CD8+ T cells and Treg cells were also imbalanced in the tumors and peripheral immune organs of mice with poor lymphocyte recovery after chemotherapy. Moreover, these mice failed to respond to anti-PD-1 antibodies but remained sensitive to the anti-PD-L1/TGF-βR fusion protein (SHR-1701). Consistently, SHR-1701 but not anti-PD-1 antibodies, markedly enhanced IFN-γ production and Ki-67 expression in peripheral CD8+ T cells from patients with impaired lymphocyte recovery.Lung cancer patients with poor lymphocyte recovery and suffering from persistent lymphopenia after previous chemotherapy are resistant to anti-PD-1/PD-L1 antibodies but might be sensitive to second-generation agents such as SHR-1701.
Biomarkers to identify <i>Mycobacterium tuberculosis</i> infection among borderline QuantiFERON results
Authors: Jonathan W. Uzorka, Jaap A. Bakker, Krista E. van Meijgaarden, Eliane M.S. Leyten, Nathalie M. Delfos, David J. Hetem, Jos Kerremans, Mieke Zwarts, Sandra Cozijn, Tom H.M. Ottenhoff, Simone A. Joosten, Sandra M. Arend
Journal: European Respiratory Journal (2022)

Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) testing. Previous studies showed that two-thirds of patients with negative QFT results just below the cut-off, so-called borderline test results, nevertheless had other evidence of TB infection. This study aimed to identify a biomarker profile by which borderline QFT results due to TB infection can be distinguished from random test variation. Methods QFT supernatants of patients with a borderline (≥0.15 and &lt;0.35 IU·mL −1 ), low-negative (&lt;0.15 IU·mL −1 ) or positive (≥0.35 IU·mL −1 ) QFT result were collected in three hospitals. Bead-based multiplex assays were used to analyse 48 different cytokines, chemokines and growth factors. A prediction model was derived using LASSO regression and applied further to discriminate QFT-positive Mycobacterium tuberculosis -infected patients from borderline QFT patients and QFT-negative patients Results QFT samples of 195 patients were collected and analysed. Global testing revealed that the levels of 10 kDa interferon (IFN)-γ-induced protein (IP-10/CXCL10), monokine induced by IFN-γ (MIG/CXCL9) and interleukin-1 receptor antagonist in the antigen-stimulated tubes were each significantly higher in patients with a positive QFT result compared with low-negative QFT individuals (p&lt;0.001). A prediction model based on IP-10 and MIG proved highly accurate in discriminating patients with a positive QFT (TB infection) from uninfected individuals with a low-negative QFT (sensitivity 1.00 (95% CI 0.79–1.00) and specificity 0.95 (95% CI 0.74–1.00)). This same model predicted TB infection in 68% of 87 patients with a borderline QFT result. Conclusions This study was able to classify borderline QFT results as likely infection-related or random. These findings support additional laboratory testing for either IP-10 or MIG following a borderline QFT result for individuals at increased risk of reactivation TB.
5-Hydroxytryptamine (Serotonin) in Human Bronchial Asthma: Experimental and Clinical Data
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Closing Africa's wide COVID-19 testing and vaccination gaps
Authors: Paul Adepoju
Journal: The Lancet Microbe (2021)

In an assessment released on Oct 14, 2021, WHO stated that only one in seven COVID-19 infections in Africa are being detected, highlighting the need to expand testing capabilities. At the time of this assessment, about 4 billion COVID-19 tests have been conducted globally, of which only about 73 million were carried out in Africa—a small fraction of the continent's 1·3 billion people.
Abstract 51: Effects of Human Immunodeficiency Virus-1 gp120 Viral Proteins on Endothelial Senescence and microRNA Expression
Authors: Jamie Hijmans, Kelly Stockelman, Whitney Reiakvam, Ma’ayan Levy, Lillian Bruster, Zoë Goldthwaite, Tyler Bammert, Jared Greiner, Elizabeth Connick, Christopher DeSouza
Journal: Circulation Research (2017)

Human immunodeficiency virus (HIV)-1 is associated with profound endothelial cell damage and dysfunction. HIV-1 envelope glycoprotein 120 (gp120) is a toxic viral protein released from infected cells and promotes endothelial cell dysfunction. Endothelial cell senescence is a key factor underlying endothelial dysfunction and, in turn, vascular disease risk. It is now clear that microRNAs (miRs) play a pivotal role in regulating cellular senescence. The aim of this study was to determine whether gp120 induces endothelial cell senescence; and if so, whether the cellular expression of senescence-related miRs (mir-34a, -146a and -217) are adversely affected by gp120. Cultured HAECs (3 rd passage) were plated at a density of 5.0x10 5 cells/condition. Cells were treated with media alone or media containing gp120: either lav gp120 (X4; 100ng/mL) or Bal gp120 (R5; 100ng/mL) for 24 h. Thereafter, cells were stained for senescence-associated β-galactosidase (β-gal) for 14 h. Cells from 5-7 random microscope fields were counted and (%) senescence was calculated as the ratio of β-gal positive cells to total cells. To determine miR expression, RNA was extracted from 1.0x10 5 cells and was quantified using RT-PCR. Cellular expression was normalized to RNU6 and calculated as fold change in ΔΔCt from control (N=4, experimental units). Both X4 (32.0±0.7% vs 18.3±1.7%) and R5 (30.2±3.8% vs 18.3±1.7%) significantly increased cellular senescence vs control. Moreover, the magnitude of increase (~65%) in senescent cells was similar between the glycoproteins. Cellular expression of pro-senescence miR-34a (1.60±0.04 fold) was increased (~60%; P&lt;0.05) in response to X4 treatment compared with control. However, expression of miR-146a (1.34±0.36 fold) and miR-217 (1.38±0.36 fold) was not significantly affected by X4. In response to R5, cellular expression of miR-34a (1.23±0.07 fold) was significantly increased (~23%) and miR-146a (1.23±0.07 fold) was significantly decreased (~80%); miR-217 was not influenced by R5 (1.05±0.13 fold). These data indicate that HIV-1 viral protein gp120 induces endothelial cell senescence and adversely affects cellular expression of senescence-associated miRs. miR dysregulation may underlie the pro-senescent effects of gp120.
A new Flexner report?
Authors: W. H. Danforth
Journal: JAMA (1969)

In 1911, Abraham Flexner issued his monumental report that was to transform American medical schools from trade schools into academies of science and learning. In his visits to the schools he had found mediocrity or worse. He left behind a legacy of excellence and an educational system which has been a model for the world. Today, more than 50 years later, this system that has been so long applauded may be outmoded. Critics have arisen. Sensitive observers have issued calls for change—radical change—calls to adapt medical education to the needs of a new and different time. In a period of flux, it is human nature to turn to the past for parallels from which to draw guidance. But, at such times, old landmarks may lose their validity. Today, many wish longingly for a new Flexner report to serve as a blueprint for modern-day medical schools. I believe that this understandable
Lottery-Based Incentives and COVID-19 Vaccination Rates in the US
Authors: Anica C. Law, Daniel Peterson, Allan J. Walkey, Nicholas A. Bosch
Journal: JAMA Internal Medicine (2022)

Lottery-Based Incentives and COVID-19 Vaccination Rates in the USOn May 12, 2021, Ohio announced a lottery system incentivizing residents to receive COVID-19 vaccinations 1 ; several US states subsequently introduced similar programs. 2Although analysis of vaccination rates from Ohio suggested that lotterybased incentives were not associated with increased vaccination rates, 3 responses to lottery programs across other states are unclear.In this study, we assessed changes in COVID-19 vaccination rates across US states with lottery-based vaccine incentives.